首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Preparation and Characterization of (MCM-41)-Carvedilol Composite Material
【24h】

Preparation and Characterization of (MCM-41)-Carvedilol Composite Material

机译:(MCM-41)-卡维地洛复合材料的制备与表征

获取原文
获取原文并翻译 | 示例
       

摘要

With sharply increase in the amount of patients with elevated blood pressure population, seeking the effective treat medicine and the loading medicine carrier becomes a hot research spot. This paper used MCM-41 to take a carvedilol medicine carrier using hydrothermal method to synthesize MCM-41 and in it carvedilol was loaded. The amount of assembly capacity was 180 mg/g (drug/MCM-41). The prepared composites were characterized by chemical analysis, powder X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy and N2 adsorption-desorption and the release law in human body simulated fluid was made. Powder X-ray diffraction showed that during the process of incorporation the framework of the molecular sieve was not destructed and crystalline degrees of molecular sieve in the host-guest composite materials prepared were still very high. FT-IR spectra showed that the frameworks of host molecular sieves of the prepared host-guest composite materials were intact. Low-temperature nitrogen adsorption-desorption results at 77 K showed that the specific surface area and the pore volume of the host-guest composite material decreased compared to those of the host molecular sieve, indicating that the guest has partially occupied the channels of the molecular sieve. Transmission electron microscopic results showed that two-dimensional hexagonal mesoporous channels of molecular sieve in the composite materials were maintained. Scanning electron microscopic results showed that the composite materials were maintained as fibrous crystals. In simulated body fluid, it is discovered by studying release law of drug in the composite materials that drug release effective time was up to 32 h and release ratio was 99.4 %. In simulated gastric fluid, composite drug release time was up to 4 h and release rate was up to 23 %. In simulated intestinal fluid, the drug release time up to 9 h can be more effective and the release rate was 72.7 %. The above results showed that MCM-41 is a well-controlled drug delivery carrier.
机译:随着高血压人群患者数量的急剧增加,寻求有效的治疗药物和载药载体成为研究的热点。本文以MCM-41为载体,采用水热法制取卡维地洛药物载体,合成了MCM-41,并在其中负载卡维地洛。组装量为180mg / g(药物/ MCM-41)。通过化学分析,粉末X射线衍射,傅立叶变换红外光谱,扫描电镜,透射电镜和N2吸附-脱附对复合材料进行表征,并确定了其在人体模拟液中的释放规律。粉末X射线衍射表明,在掺入过程中,分子筛的骨架没有破坏,所制备的客-客复合材料的分子筛结晶度仍然很高。 FT-IR光谱表明所制备的主体-客体复合材料的主体分子筛的骨架是完整的。 77 K的低温氮吸附-解吸结果表明,与客体分子筛相比,客体-客体复合材料的比表面积和孔体积减小,表明客体部分占据了分子通道。筛。透射电子显微镜结果表明,复合材料中分子筛的二维六角形介孔通道得以保持。扫描电子显微镜结果表明,复合材料保持为纤维状晶体。在模拟体液中,通过研究复合材料中药物的释放规律,发现药物释放有效时间长达32 h,释放率为99.4%。在模拟胃液中,复合药物释放时间长达4 h,释放率高达23%。在模拟肠液中,长达9小时的药物释放时间可能更有效,释放率为72.7%。以上结果表明,MCM-41是一种控制良好的药物输送载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号